[Edaily Reporter Kim Jeong-yu] #Lotte Tour Development announced on the 17th that it will expand the size of the children’s (kids’) section at “Han Collection,” a Korean goods shopping mall located within the Jeju Dream Tower Complex Resort. Photo: Lotte Tour Development As a result, the Han Collection Kids store will be expanded approximately tenfold, from its current size of about 33.94 square meters (approximately 10 pyeong) to 367.24 square meters (approximately 111 pyeong). Additionally, the product categories have been diversified to include clothing for newborns through school-age children, as well as various sundries, art supplies, toys, and children’s cosmetics (beauty products).
A company official stated, “The whole family can now enjoy one-stop shopping in one place,” adding, “We expect it to quickly establish itself as a must-visit shopping destination for global tourists traveling with families, thanks to the synergy between Dream Tower’s strengths—including its excellent accessibility from Jeju Airport and the infrastructure of the five-star Grand Hyatt Jeju.”
Located on the 3rd and 4th floors of Jeju Dream Tower, Han Collection is a space where shoppers can discover over 450 brands in one place.
A Han Collection representative noted, “As the status of K-fashion continues to rise, we are seeing a steady increase in purchase rates not only among the domestic MZ generation seeking to express their individuality but also among foreign tourists looking to experience Korean fashion culture.”
This week (October 6–8), startups across various sectors—including defense, biotech, and artificial intelligence (AI) image-generation platforms—secured investments from venture capital (VC) firms and…
SK Group Chairman Choi Tae-won announced plans to establish a semiconductor production hub in the Honam region that would be two-thirds the size of the Yongin Semiconductor Cluster. He also left open …
South Korea’s pharmaceutical and biotech stocks posted mixed results on Oct. 8, with Peptron plunging nearly 30% after its technology evaluation with Eli Lilly concluded without a follow-on commercial…